Tobias Insurance agency merges with Florida firm
Tobias Insurance, the Indianapolis area’s eighth-largest independent insurance brokerage, is now part of Florida-based AssuredPartners. Tobias will retain its name, employees and leadership.
Health Care & Insurance
Articles
Lilly settles with four sisters in DES cancer case
Four sisters who claimed their breast cancer was caused by a drug their mother took during pregnancy in the 1950s reached a settlement Wednesday with Eli Lilly and Co. in the first of scores of similar claims around the country to go to trial.
WellPoint draws criticism for California rate increase
WellPoint Inc.’s plan to raise the rates for small employers in California was criticized as unreasonable by the state insurance commissioner, who said customers are being charged this year to cover U.S. health-law fees that won’t begin until 2014.
Drug sold by Lilly caused cancer, women claim at Boston trial
In opening statements Tuesday, a lawyer for Indianapolis-based Lilly told the jury there is no evidence the synthetic estrogen known as DES causes breast cancer in the daughters of women who took it.
WellPoint says earnings could slightly exceed expectations
WellPoint Inc. said Tuesday that it expects 2012 earnings at the high end or slightly above a range that the health insurer reaffirmed last month.
Fiscal cliff deal threatens Indiana co-op health plan
Last week’s fiscal cliff bargain in Congress dealt a potentially fatal blow to a new health insurance plan, called Remedy Indiana, that was set to launch this year.
Spotlight falls on IU Health for flu shot firings
Indiana University Health got national attention last week for its decision to dismiss eight employees for refusing to get a flu vaccination. The Indianapolis-based hospital system fired three nurses and five other employees from its IU Health Goshen Hospital.
Big drug deals expected to return in 2013
Pharmaceutical companies including Pfizer Inc., Bristol-Myers Squibb Co. and Eli Lilly and Co. could be ready to start making major acquisitions again.
Lilly’s 2013 profit forecast tops expectations
Eli Lilly and Co. forecasts its 2013 earnings will grow more than Wall Street expects even though the drugmaker will lose U.S. patent protection for two more key products in the new year.
Trial set to begin over pregnancy drug sold by Lilly
Four sisters diagnosed with breast cancer are suing Eli Lilly and Co., a former maker of DES, or diethylstilbestrol, a drug taken by their mother in the 1950s when she was pregnant. It could be the first of scores of such trials over the drug.
Decline in fitness club memberships pushes NIFS into arms of seniors
Health club on campus of IUPUI makes up for lost revenue by managing fitness and wellness programs for retirement communities.
CNO’s Bonach has insurance firm back on offense
CNO Financial Group’s stock price has nearly doubled since Ed Bonach took the helm in October 2011. Some analysts that follow the successor to Conseco Inc., which a decade ago was the nation’s third-largest Chapter 11 bankruptcy reorganization, now regard CNO as an attractive value play.
Stock buyback continues at CNO
The Carmel-based owner of Bankers Life and other insurance companies has seen its stock rise as it restructures debt.
Fort Wayne church insurer plans to add 102 jobs
Brotherhood Mutual Insurance Co. expects to hire the employees by 2016 as part of a $15 million expansion that includes building a 54,395-square-foot facility at its headquarters.
WellPoint completes $4.5B Amerigroup acquisition
The deal gives the Indianapolis insurer a bigger slice of the growing market of patients covered by Medicaid, the federal-state health program for low-income people.
Women’s physician building targeted for foreclosure
A lawsuit from the lender claims that Women’s Physician Group still owes $8.7 million on a $9 million loan it received for a northwest-side building.
Lilly agrees to pay $29.4M to settle SEC bribery charges
According to a statement released by the SEC, Eli Lilly paid $6.5 million—and in some cases gave jewelry and spa treatments—to win government contracts in Brazil, China, Russia and Poland.
Indiana to receive nearly $793K in Amgen settlement
Amgen Inc. has agreed to pay Indiana nearly $793,000 as part of a larger settlement to resolve allegations it paid kickbacks to physicians who prescribed some of its drugs for unapproved uses.
Lilly OKs $1.5B share buyback, first quarter dividend
Indianapolis-based drugmaker Eli Lilly and Co. said Monday that its board authorized a $1.5 billion share-repurchase program, which the company expects to complete next year.
Lilly finds solace in new Alzheimer’s study
Eli Lilly and Co. suffered a delay in its effort to bring an Alzheimer’s drug to market this month, but it also published new research that the pharmaceutical company thinks confirms it is on the right track.